Comment to Sylwia Olechnowicz-Tietz et al.: the risk of atherosclerosis in patients with chronic kidney disease

被引：0
|
作者：
Yuan Cheng
Nan Mao
Junming Fan
机构：
[1] Sichuan University,Division of Nephrology, West China Hospital, West China Medical School
[2] Affiliated Hospital of Luzhou Medical College,Department of Nephrology
来源：
International Urology and Nephrology | 2013年 / 45卷
关键词：
Atherosclerosis; Chronic Kidney Disease; Serum Creatinine; Glomerular Filtration Rate; Acute Coronary Syndrome;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1243 / 1244
页数：1
相关论文
共 50 条
  • [21] Comment on "Sublingual capnometry tracks microcirculatory changes in septic patients" by Creteur et al. - Reply to the comment by Dr. Hasibeder et al.
    Creteur, Jacques
    Vincent, Jean-Louis
    INTENSIVE CARE MEDICINE, 2006, 32 (10) : 1667 - 1667
  • [22] RESPONSE TO COMMENT ON NIEWCZAS ET AL. Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease. Diabetes Care 2017;40:383-390
    Niewczas, Monika A.
    Krolewski, Andrzej S.
    DIABETES CARE, 2017, 40 (08) : E109 - E110
  • [23] Comment on Chen et al.: Impact of chronic kidney disease on outcomes after total joint arthroplasty: a meta-analysis and systematic review
    Xiao, Shuiman
    Zhang, Hanchong
    INTERNATIONAL ORTHOPAEDICS, 2020, 44 (05) : 1013 - 1014
  • [24] On the analysis of risk-sensitive foraging: a comment on Codding et al.
    Koster, Jeremy
    PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2011, 278 (1722) : 3171 - 3172
  • [25] Comment on Chen et al.: Impact of chronic kidney disease on outcomes after total joint arthroplasty: a meta-analysis and systematic review
    Shuiman Xiao
    Hanchong Zhang
    International Orthopaedics, 2020, 44 : 1013 - 1014
  • [26] Risk factors of atherosclerosis in patients with spondylarthropathies: comment on the article by Gonzalez-Juanatey et al - Reply
    Gonzalez-Gay, Miguel A.
    Gonzalez-Juanatey, Carlos
    Martin, Javier
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2008, 59 (03): : 455 - 456
  • [27] Febuxostat for patients with gout and severe chronic kidney disease: which is the appropriate dosage? Comment on the article by Saag et al Reply
    Saag, Kenneth
    Gunawardhana, Lhanoo
    ARTHRITIS & RHEUMATOLOGY, 2016, 68 (10) : 2564 - 2564
  • [28] Reply to Lissing et al. Comment on "Ramai et al. Risk of Hepatocellular Carcinoma in Patients with Porphyria: A Systematic Review. Cancers 2022, 14, 2947"
    Ramai, Daryl
    Deliwala, Smit S.
    Chandan, Saurabh
    Lester, Janice
    Singh, Jameel
    Samanta, Jayanta
    di Nunzio, Sara
    Perversi, Fabio
    Cappellini, Francesca
    Shah, Aashni
    Ghidini, Michele
    Sacco, Rodolfo
    Facciorusso, Antonio
    Giacomelli, Luca
    CANCERS, 2023, 15 (04)
  • [29] Comment on 'Association Between Dynapenic Obesity and Risk of Cardiovascular Disease: The Hisayama Study' by Setoyama et al.
    Liu, Chang
    Zhang, Fan
    Cao, Min
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2025, 16 (01)
  • [30] Comment on 'Association Between Dynapenic Obesity and Risk of Cardiovascular Disease: The Hisayama Study' by Setoyama et al.
    Wang, Han
    Huang, Yizhuan
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2024,
12345